AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca right-of-use (ROU) lease assets — net carrying value ($M) ($M)
Form 20-F Note 9 — Leases (Right-of-Use Assets)
Latest, FY2025
1,741
Period ended Dec 31, 2025
Change on a year earlier
+24.8%
1,395 in FY2024
History
8 years
Since FY2018
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Right-of-use (ROU) lease assets — net carrying value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,741 | +24.8% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 1,395 | +26.8% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 1,100 | +16.8% | Form 20-F FY2024 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 942 | -4.7% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 988 | +48.3% | Form 20-F FY2023 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 666 | +2.9% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 647 | -10.4% | Form 20-F FY2022 Annual Report ↗ |
| FY2018 | Dec 31, 2018 | 722 | – | Form 20-F (filed 2021-02-16) ↗ |
Breakdown
What makes up right-of-use (rou) lease assets — net carrying value ($m)
Cite this data
StockData. (2026). AstraZeneca Right-of-use (ROU) lease assets — net carrying value ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rou_net_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.